Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9169182
Chrysophaentin analogs that inhibit FtsZ protein
granted -
US 9169297
Subgenomic replicons of the flavivirus dengue
granted -
US 9168297
Regulation of skin pigmentation by neuregulin-1 (NRG-1)
granted -
US 9168266
Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer
granted -
US 9163258
Method for the treatment of obesity
granted -
US 9163068
Influenza virus recombinant proteins
granted -
US 9163236
Pharmaceutical composition comprising NANOG SHRNA, and method of using NANOG SHRNA to treat cancer
granted -
US 9163244
Suppressors of CpG oligonucleotides and methods of use
granted -
US 9150644
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
granted -
US 9150926
Diagnosis and treatment of adrenocortical tumors using human microRNA-483
granted -
US 9151762
Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes
granted -
US 9144604
Vaccine for Shigella
granted -
US 9139595
Biologically active macrolides, compositions, and uses thereof
granted -
US 9140687
Renal cell carcinoma biomarkers
granted -
US 9133250
Proteins with repetitive bacterial-Ig-like (Big) domains present in Leptospira species
granted -
US 9133253
Ricin vaccine and methods of making thereof
granted -
US 9133480
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted -
US 9132135
Method of treating organophosphorous poisoning
granted -
US 9133478
Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences inserted into the intergenic regions between essential genes
granted -
US 9125923
Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy
granted -
US 9128080
Modified T cell receptors and related materials and methods
granted -
US 9127056
Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth factor II (IGF-II)
granted -
US 9120867
Lutzomyia longipalpis polypeptides and methods of use
granted -
US 9119828
Antibodies with simultaneous subsite specificities to protein and lipid epitopes
granted